• PacRoots Cannabis employs genetic modification to customize cannabis strains in bid to enhance product potency, quality
• Company has strategic licensing agreement with Phenome One, a bio-tech firm boasting a database of over 350 unique live cannabis strains
• Partnership allows PacRoots ability to optimize genetic makeup of its cannabis crop based upon plant’s intended end use
• Use of genetic modification can also help companies cultivate plants which are better suited towards overall yield enhancement, thereby boosting overall profit margins

In the late 1860s, Friar Gregor Mendel, an Augustinian monk and scientist living in a monastery in the depths of the Austrian empire, set about cross-breeding different species of garden pea plants – an experiment which would ultimately plant the seed for genetic modifications in modern agriculture. Over 150 years later, the cannabis industry is picking up from where Friar Mendel left off. PacRoots Cannabis (CSE: PACR), a Canada-based company, has sought to adopt a genetics-focused approach towards producing premium quality cannabis products—positioning itself to become a trailblazer in providing industry-leading strains not currently available in the regulated market.

PacRoots expects to be cash flow positive within its first year of trading following the sales from the 100-acre Hemp Project, in Rock Creek, BC. The company has embraced Phenome One’s growing IP, methods and systems; including systematic planting of young hardy plants in rows vs a seed spread, advanced weed suppression and a rigorous nutrient formulae and irrigation regime that will drive quality and yield (http://ibn.fm/OVwjG).

As part of the agreement, PacRoots Cannabis will gain access to Phenome One’s database of over 350 unique, live cannabis strains, which have been carefully field-tested and artificially selected over 30 years of research. Acquiring the ability to optimize the genetic makeup of its cannabis plants will enable PacRoots Cannabis to not only develop unique strains featuring a variety of beneficial characteristics but also enhance the potency, bud quality and overall yield of its plants.

“This is a major opportunity for PacRoots to be positioned to offer customers an extensive collection of cannabis cultivars,” said PacRoots CEO and President Patrick Elliot. “At PacRoots, we pride ourselves and our customers with quality and we are thrilled with the opportunity to partner with Phenome One, establishing a robust cultivar portfolio that compares favorably over others in the Canadian cannabis space” (http://ibn.fm/G7tJr).

The use of artificial selection and marker-assisted breeding has enabled cannabis cultivators to optimize the size, color, smell, density and texture of the resulting cannabis crop – thereby allowing for particular strains to be customized depending on their end-use. Whether it be proprietary high-THC strains, cannabidiol-dominant strains with rare terpene profiles, or custom strains finely tailored for medical purposes (http://ibn.fm/NzrCU), the ability to visualize, control and potentially modify the genetic structure of their marijuana plants allow cannabis companies to maximize the quality of their products. Moreover, the use of genetic modifications has allowed companies to boost the overall profitability of their businesses by enhancing plant yields – for instance, selecting genetic makeups which result in larger and more numerous buds on each plant can help PacRoots Cannabis ultimately grow more cannabis per grow light.

“You can get more yield off of a plant if you can refine the genetics and that allows us to have more grams, more kilograms coming out of this place per year,” explained Canopy Growth’s Vice President of communications Jordan Sinclair during a 2019 interview at the company’s Tweed Farms operations (http://ibn.fm/XZ90J).

With the use of cannabis-based products gaining increasing prominence and acceptance across wide swaths of society, the need to enhance and differentiate cannabis products through their genetic makeup is rapidly becoming a priority for cultivators in the sector.  Through its pioneering approach towards producing premium-grade cannabis strains, and following its tie-up with Phenome One, PacRoots Cannabis is well on its way towards creating a unique foothold for itself within the global cannabis industry.

For more information, visit the company’s website at www.PacRoots.ca.

NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://ibn.fm/PACR

• NETE releases Q2 2020 financial report
• CEO notes impact of COVID-19 on financial results, points to continued efforts to increase shareholder value as merger approaches
• Shareholder letter provides clarification on expected number of shares

Net Element (NASDAQ: NETE), a global financial technology and value-added solutions group, released its financial report for Q2 2020 (http://ibn.fm/d1h9G), the period ended June 30, 2020; NETE also provided more clarifying information about its pending merger with Mullen in an Aug. 19 shareholder letter (http://ibn.fm/W1ahe).

In its financial report, NETE noted that, during second quarter 2020, total transaction volume decreased to $717.9 million, as compared to $950.2 million for the same comparable period the year previous. In addition, net revenue decreased to $13.7 million, as compared to $16.5 million for Q2 2019. Operating expenses decreased to $2.2 million, as compared to $5.2 million for the same comparable period. Gross margin for the quarter decreased to $2.2 million compared to $2.6 million for Q2 2019.

“The COVID-19 pandemic continued to negatively impact our financial results during the second quarter of this year,” said Net Element CEO Oleg Firer. “Our ability to adapt quickly by implementing safety protocols to protect our employees has been successful so far, and we are happy to report we have had zero cases of COVID-19 among our employees. We also implemented cost-cutting initiatives while boosting support for our merchants through e-commerce solutions, contactless payment alternatives and online food ordering for restaurants. We continue working diligently to increase shareholder value as we continue to work toward the proposed merger with Mullen Technologies Inc.”

On August 5, 2020, Net Element announced the execution of a definitive agreement to merge with privately held Mullen Technologies Inc., a Southern California-based electric vehicle company, in a stock-for-stock reverse merger in which Mullen’s stockholders will receive a majority of the outstanding stock in the post-merger company (http://ibn.fm/zDnEP). The completion of the merger is subject to shareholder and NASDAQ approval, as well as other conditions referenced in the merger agreement.

Firer provided clarification regarding the upcoming merger in a recent shareholder letter. “Since announcing the contemplated merger, we have received a number of inquiries from shareholders requesting clarification regarding the expected number of shares that will be outstanding at closing if the pending merger with Mullen were to be approved,” the letter states. “The Merger Agreement provides for a cap of 75 million outstanding shares at the closing of the transaction which cannot be exceeded without both parties’ approval; however, this is a maximum number, and there is no way of knowing the actual number of shares that will be outstanding at that time.”

Firer notes that, if the share price on the transaction closing date is the same as the closing price on August 18, 2020 (the day before the letter was released), NETE anticipates that the number of shares outstanding at closing will be approximately 50 million. “If the share price on the transaction closing date is less than the closing price on August 18, 2020, the company anticipates that the number of shares outstanding at closing will be greater than 50 million but subject to the 75 million share cap,” the letter said.

Net Element Inc. is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce and mobile devices. The company operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets.

For more information, visit the company’s website at www.NetElement.com.

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE

• Trxade Group Inc. is a supplies and services innovator for the pharmaceutical industry, working to keep small retailers competitive with large chains and costs accessible for end-use patients
• Trxade Group has seen its brand grow significantly during the past year, adding a 244 percent year-over-year increase to its quarterly revenues during the spring
• The company will further draw attention to its profile by joining other brand presentations at the LD 500 Virtual Investor Conference scheduled to begin Sept. 1 and run through the week
• The LD 500 conference is designed to provide an online-accessible meeting of small cap companies and potential investors even during the ongoing global pandemic, and it is open to everyone

Trxade Group (NASDAQ: MEDS) will introduce a raft of potential new investors to the accomplishments of its growing brand in the medical technology space when CEO Suren Ajjarapu makes a 20-minute presentation on the company as part of the upcoming LD 500 Virtual Investor Conference.

Ajjarapu will also interact more directly with sanctioned LD 500 patrons who are curated through the event’s network, holding one-on-one interviews with potential investors during the hours surrounding his 1:40 p.m. EST presentation on Wednesday, Sept. 2 (http://ibn.fm/nlt6c).

The LD 500 conference is designed to attract hundreds of leading names in the microcap markets space as well as potential sources of capital for the companies. The convention and conference industry has been battered by the distancing demands of the novel coronavirus pandemic but LD 500 organizers have adapted with their most ambitious gathering to date — up to 500 companies and tens of thousands of participants registered for the four-day virtual investor summit that begins Sept. 1, with pre-event activities slated this coming Monday, Aug. 31 (http://ibn.fm/U9diD).

Trxade Group has been building its B2B platform into a B2C-friendly portfolio that helps independent local pharmacies compete with large-scale retail chains through drug pricing transparency and network strength, also helping health patients to gain telemedicine access to physicians’ clinics without leaving home, and to have prescriptions ordered online and delivered to the home (http://ibn.fm/9zSca).

Trxade Group’s platform also provides assistance with buying personal protective equipment (“PPE”) for businesses challenged by the ongoing global pandemic and the wellness needs of employees carrying out company assignments.

“This platform resolves a fundamental trust problem impacting employer’s safety and security policies, allowing companies to more effectively combat COVID-19 concerns in the workplace,” Bonum Health President Ashton Maaraba stated. Bonum Health is a subsidiary of Trxade Group.

Trxade’s flagship operation has achieved more than 50 percent penetration of its intended market, the 22,000 independent pharmacies across the United States that serve their communities with features not too far removed from the corner drugstore days of the past century.

“We believe this radical price transparency, economy of scale and competition amongst suppliers leads (to) up to 10% reduction in pharmacies’ total annual drug purchase costs, with a drug-level savings of up to 90% on certain pharmaceutical products,” Ajjarapu said in a recent earnings conference call (http://ibn.fm/zc0Wf).

Trxade Group reported those Q2 financial results in July, noting the company’s revenues had grown by 244 percent year-over-year for the quarter, and by 199 percent sequentially from the first quarter of the year.

For more information, visit the company’s website at www.TrxadeGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

• InsuraGuest Technologies, Inc. will be able to use Swarts, Manning & Associates’ business and broker network in California, Nevada and Utah
• The insurance firm’s hotel clients will gain access to InsuraGuest’s Hospitality Liability policy following integration of its insurtech platform with their property management systems
• The agreement is expected to improve the risk profile of Swarts, Manning & Associates’ hospitality clients by lowering their risk and claim ratios

InsuraGuest Technologies (TSX.V: ISGI) is set to expand the reach of its insurtech product in the hospitality sector after signing full-service insurance firm Swarts, Manning & Associates for its agency/broker program. According to a company new release, the agreement was signed through the company’s wholly-owned subsidiary InsuraGuest Insurance Agency, LLC (http://ibn.fm/CLc2O).

As part of its agency/broker program, InsuraGuest will use Swarts, Manning & Associates’ network in California, Nevada and Utah to access the insurance company’s hotel clients and provide them with InsuraGuest’s Hospitality Liability policy coverage by integrating its insurtech software platform with the hotels’ management systems.

Swarts, Manning & Associates was founded in 1996 and quickly became a leader and innovator in the insurance industry. Dedicated to providing the most cost-effective and customized insurance solutions, the firm has several specialized departments dedicated to personal insurance, health benefits, commercial insurance and more.

“Our focus has always been on risk management and improving the risk profile of our hospitality clients,” states Mark Swarts, founder and president of Swarts, Manning & Associates. “Adding InsuraGuest’s products to our partner list will help us reduce their hotel clients’ risk ratios and claim ratios while potentially lowering their GL premiums.”

InsuraGuest’s goal is to disrupt the insurance landscape by utilizing its proprietary software platform to deliver digital insurance to multiple verticals. The company aims to transform the way insurance is delivered with the revolutionary idea that insurance should be bought, not sold.

The company’s insurance coverage is purchased by the property and automatically delivers Hospitality Liability policy coverages through the property’s management system after integration of InsuraGuest’s proprietary insurtech platform. InsuraGuest Hospitality provides coverage for accidental property damage, theft of the guest’s personal property while residing at the vacation rental property, as well as accidental medical expenses and accidental death and dismemberment.

InsuraGuest’s platform currently integrates with approximately 70 different hotel property management systems, including Hilton -ONQ, Marriott Fosse, Marriott Full Service, Oracle Opera, Springer-Miller Systems, Agilysys and Lightspeed GPS.

The deal with Swarts, Manning & Associates follows a partnership signed with Hostfully, a provider of end-to-end vacation rental property management software. The agreement allowed InsuraGuest to make available its Hospitality Liability coverage to Hostfully’s client base of more than 2,5000 vacation rental properties.

This is encouraging news for InsuraGuest’s investors, given the significant growth potential of the vacation rental market. With over $57 billion in rental revenue in 2019 and a growth rate of 6.9%, the industry continues its growth as more and more people each year take advantage of the variety of benefits that vacations rentals offer (http://ibn.fm/OWkVZ). Additionally, there is significant growth potential for the company on the European hotel and vacation rental market, currently twice larger than the U.S. market size.

The agreements with Swarts, Manning & Associates and Hostfully, respectively, reaffirm InsuraGuest Technologies’ commitment and dedication to harnessing the power of technology to reinvent insurance across multiple verticals, including the hospitality sector.

The company is also taking active steps to diversify its insurance product offering across multiple sectors. In June, through its wholly owned U.S. subsidiary Insure The People, LLC (“ITP”), InsuraGuest announced the development of a new Business Owner Policy (“BOP”) insurtech portal, www.InsureThePeople.com, slated for release to U.S. markets by the third quarter of 2020 (http://ibn.fm/AwrIF). According to InsuraGuest Chairman and CEO Douglas Anderson, the new product has the potential to provide the company with multiple avenues of revenue and greater shareholder value.

For more information, visit the company’s website at www.InsuraGuest.com.

NOTE TO INVESTORS: The latest news and updates relating to ISGI are available in the company’s newsroom at http://ibn.fm/ISGI

• Sustainable investing saw record increases despite overall market downturn in Q1 2020
• ESG ratings take into account environmental, social and governance factors of interest to investors
• SGTM operates with mission to serve, protect environment while providing synergistic solutions to waste disposal problems
• SGTM Q2 2020 results include over $12.3 million in revenue, $3.4 million in gross profit, nearly doubled from Q1

Investment markets post-COVID-19 saw record first-quarter inflows to sustainable funds that take environmental, social and governance (“ESG”) ratings into account, along with traditional financial metrics (http://ibn.fm/2EG5j). Sustainable Green Team (OTC: SGTM), a leading provider of environmentally-beneficial solutions for tree and storm waste disposal, experienced impressive gains alongside this market shift through a surge in its activities that transform natural waste into useful organic products that benefit the environment

Environmental, social and governance factors are increasing in importance among investors—particularly those focused on issues concerning environmental waste, climate change, resource scarcity, labor practices and product safety. Despite recent market turmoil and extreme price volatility, many ESG-focused funds have outperformed the broader market this year (http://ibn.fm/GQQK2), suggesting an overall change in sentiment among investors that prioritize ESG issues as a part of their investment strategy. SGTM is among those companies that takes ESG factors seriously, making environmental stewardship central to its operations.

“At the end of the day it’s important to share that belief that we are stewards of the environment, and that shouldn’t be understated,” said SGTM CEO Tony Raynor in a recent interview (http://ibn.fm/aQNji). “We really enjoy it, and we’re passionate about what we do.”

Formerly known as National Storm Recovery Inc., SGTM provides synergistic and environmentally beneficial solutions to tree and storm waste disposal that would otherwise create an environmental burden on landfills and disposal sites throughout the United States. Through its subsidiaries, the company provides tree services, debris hauling, and waste removal in its overall effort to transform organic waste into products such as mulch and playground surface material. The company recently announced its impressive Q2 results that include over $12.3 million in revenue and $3.4 million in gross profit (http://ibn.fm/GhZC9) – almost double its Q1 results of $6.2 million and $1.7 million, respectively (http://ibn.fm/iiwQT).

STGM’s explosive growth can be attributed to several factors in line with its corporate strategy that is focused on expansion, investment and revenue stream diversification. The company recently acquired Mulch Manufacturing Inc., a 35-year-old industry leader and innovator in mulch manufacturing that significantly expanded SGTM’s footprint through its established networks in sales, distribution and production. Along with the acquisition were significant corporate investments that included the purchase of grapple hauling trucks and construction upgrades to its waste management landfill facility, enabling the company to increase production of its organic next-generation mulch products and playground surface material.

With a focus on ESG principles, SGTM takes its mission of protecting and serving the environment seriously, providing solutions for tree and storm waste disposal that otherwise would have created a burden on local landfills and waste disposal sites. Despite the current economic environment, SGTM continues to grow as demand for its services increases among its wide range of public and private-sector clients.

To learn more about Sustainable Green Team Ltd., view the investor presentation at http://ibn.fm/jvrhi.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

• Company focused on furthering R&D of psilocybin-based medications
• Cybin believes psychedelic substances derived from mushrooms can work as boosters for brain
• Psilocybin shows promise for an array of mental health issues

Cybin Corp. is a leading life-science company focused on psychedelic and nutraceutical products to support various psychiatric and neurological conditions. The company is engaged in clinical trials, through a partnership with the Toronto Centre for Psychedelic Science (“TCPS”) to gain regulatory approval for psilocybin and other psychedelic products (http://ibn.fm/RgpQc).

In the 1940s, the study of psychedelic drugs for the treatment of mental health conditions began with the discovery of LSD. However, President Richard Nixon put a stop to this research in the 1960s with his war on drugs. Only recently have researchers began to explore psychedelics once again. This research is showing positive results in the treatment of depression, anxiety, PTSD, addictions, eating disorders, ADHD and more.

This evolution couldn’t be more timely. In the midst of a worldwide pandemic, the need for anxiety-reducing therapies has grown substantially, and psychedelics may have the potential to make a profound impact. Clinical studies for PTSD and psilocybin therapy for treatment-resistant depression has won the acknowledgment of the FDA (http://ibn.fm/V3HpZ). The combined cooperation of the FDA and investors is breaking down previous barriers. Psychedelic treatment may soon become mainstream.

Cybin believes that psychedelic substances derived from mushrooms can work as boosters for the brain, potentially rebuilding pathways and breaking negative patterns. Today more than 700 million people around the world struggle with mental illness, addiction or eating disorders — all areas where the benefits of psychedelic substances is being studied. What’s more, even though over 40 million Americans are taking psychiatric drugs, Big Pharma has not produced any new drug innovations in the last ten years (http://ibn.fm/yuVvc).

The world is changing quickly, and people are looking for new and improved options for managing their health. Right now, only 10% of fungi species are taxonomically classified, leaving an enormous potential for future medical research. Cybin is at the forefront of that research, paving the way for new advances and leveraging its expertise in the world of medicinal mushrooms.

Cybin operates in the functional-mushroom market with a goal to develop fungi-derived medicinal products to treat mental illness and other health conditions. The business model of this early-stage, life-sciences company includes two wholly owned core subsidiaries: Serenity Life Sciences, focusing on advancing research and development of psilocybin-based pharmaceutical products, and Natures Journey Inc., developing medicinal nonpsychedelic nutraceutical products.

For more information about this company, please visit www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to Cybin are available in the company’s newsroom at http://ibn.fm/Cybin

• SGMD, BudCars cannabis delivery service set to break sales, profits, customer orders records
• BudCars demonstrating “accelerating growth,’ represents significant period-over-period upside potential
• Company remains on track to reach $11 million benchmark for annualized sales by the close of calendar Q3

With August wrapping up, Sugarmade (OTCQB: SGMD), a product and branding marketing company investing in operations and technologies with disruptive potential, expects the month-end numbers for BudCars Cannabis Delivery Service to set multiple performance records for sales, gross profits and total customer orders (http://ibn.fm/aLwaC).

“[The] BudCars Sacramento hub continues to demonstrate accelerating growth that suggests we still haven’t really found the ceiling here in terms of period-over-period upside potential,” said Sugarmade CEO Jimmy Chan. “Ultimately, this is gratifying to see because we have taken a unique approach to retail cannabis product distribution.”

Based on mid-July analysis and projections, BudCars appeared to be on a trajectory to meet or exceed previously identified goals of $650,000 in total sales and more than 5,000 individual customer orders for July; if met, those numbers continue an impressive streak of sequential month-over-month topline growth at or above the company’s target 30% level.

In addition, this consistent upward trends puts the company right in line to reach — or exceed — the $11 million benchmark for annualized sales by the close of calendar Q3, which the SGMD executive team announced previously in its updated guidance materials (http://ibn.fm/QOoIW).

Sugarmade is also on right on track with other strategic plants to leverage the current cannabis market needs. “We are pursuing three primary avenues to drive growth: organic execution, geographic expansion, and verticalization of our supply chain,” said Chan. “In each case, we continue to make progress. However, at this point, we have only scratched the surface of what is possible over the intermediate term for BudCars given that all of the growth we have booked so far has been exclusively about organic execution as we claim an increasing share of the market and drive enthusiastic repeat business from newly acquired customers.”

Specifically, SGMD has plans to launch new BudCars locations in the Los Angeles regional market and is pursuing the incorporation of in-house cultivation and cannabis product manufacturing at a new 5,000 square-foot, indoor, premium-cannabis cultivation facility located near its Sacramento BudCars hub.

BudCars is a retail business that offers same-day delivery of top-quality cannabis. Customers choose from a variety of products, including edibles, flower, pre-rolls, vapes, tinctures and concentrate across dozens of premium brands. Once consumers complete their purchases online, they receive their order the same day via BudCars Cannabis Delivery Service.

Sugarmade Inc. is a product and branding marketing company investing in operations and technologies with disruptive potential. In addition to its financial interest in the BudCars brand, SGMD’s brand portfolio includes CarryOutsupplies.com and SugarRush(TM).

For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

• Company’s Standard Processing License pending approval from Health Canada
• After licensing approval, Pure Extracts will be launching white label production as part of core services
• Pure Extracts facility designed to produce high-quality, high-purity formulations on a commercial scale

Pure Extract Technologies, a Canadian plant-based extraction company operating in the functional medicinal mushrooms space, is preparing to become a leading contender in the white labeling space. The Company’s Standard Processing License is currently pending approval from Health Canada; upon approval the Company will be launching white label production as part of its core services.

As an expert in the extraction field, Pure Extracts provides white label solutions based on custom formulating high-quality oils sourced from both cannabis and hemp-biomass products. In addition, the Company offers impressive expertise in designing and manufacturing consumer-ready packaging for customers.

White label products, which are products made by one company and then packaged and sold by other companies under various brand names, can provide substantial time, energy and financial savings in terms of production and marketing (http://ibn.fm/7KVnv). The practice has been steadily growing and often allows a company to offer quality products that they would otherwise be unable to provide.

As a leading extraction company, Pure Extracts is able to rapidly develop and commercialize extraction systems for plant-based medicine products. The Company has a centralized 10,000-square-foot facility built to EU-GMP standards and designed for proprietary and white label production; the facility is located in Pemberton, British Columbia. A phase 2 plan currently under development will expand the facility to 25,000 square feet and build it to EU-GMP standards, allowing the Pure Extracts to offer international distribution.

Designed with future growth in mind, the facility includes a dedicated lab that provides invaluable research and development services, is easily scalable, and offers modern CO2 and ethanol extraction capabilities and processes. The Company is designed to produce high-quality, high-purity formulations on a commercial scale.

In short, for companies licensed to sell specialized oil extracts and for CPG brands seeking licensed manufacturing partners, Pure Extracts offers a one-stop solution that ensures expert production and manufacturing resulting in top-quality products.

Pure Extracts is positioned to enter the commercial cannabis sector as an experienced producer. Led by a team of qualified experts in the space and providing cutting-edge CO2 and ethanol extraction technology, the Company is set up for long-term strategic distribution and product innovation.

For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts are available in the company’s newsroom at http://ibn.fm/Pure

• SGTM receives approval to accept debris, manufacture mulch at state-of-the art Jacksonville facility
• Approval latest in notable list of milestones for expanding company
• After posting record Q2 revenue numbers, CEO predicts another positive quarter

In yet another significant moment for the growing company, Sustainable Green Team (OTC: SGTM) received permit approval to accept debris and manufacture mulch at its largest facility, located in Jacksonville (http://ibn.fm/hwtcU). SGTM is a leading provider of environmentally beneficial solutions for tree and storm waste disposal.

“Another major achievement for our team and shareholders,” said SGTM CEO and director Tony Raynor. “Not only does this approval allow us to expand our services, it allows us to open a retail mulch supply location for retail customers; the infrastructure is already in place. I look forward to sharing more about our new approved site as well as many other updates as they progress.”

SGTM’s state-of-the-art, 100,000-square-foot Jacksonville facility sits on 28 acres of concrete and is ideally structured for the company to continue to pursue the strategic expansion of its debris collection and grapple hauling services. Permit approval came from the Jacksonville City Council, which voted on the ordinance with no opposition.

Other milestones for the company this year have included the addition of new grapple hauling trucks to its fleet (http://ibn.fm/7T4nt); the construction completion of a dual-line mulch bagger and fully automated electric grinding screening operation at its Apopka, Florida, landfill facility (http://ibn.fm/2iHxk); and the diversification of revenue stream by receiving International Play Equipment Manufacturers Association (“IPEMA”) certification and approval to manufacture tree-waste material into playground surfacing material (http://ibn.fm/zLvSr).

In addition, SGTM released impressive figures for Q2 2020, recording $12,382,491 in revenue, $3,458,164 in gross profit, and $40,710,954 in total assets, with a strong position of $7,004,807 in cash and liquid investments (http://ibn.fm/B6Xmb).

“We are very pleased with our performance and direction,” said Raynor. “The positive recorded numbers were generated prior to achieving IPEMA certification for public surfacing material, which diversified our revenue stream; prior to construction at our Waste Management landfill facility, which further increased mulch manufacturing; and prior to the addition of new grapple hauling trucks to our fleet, which increased efficiency and production. The subsequent events look to lead us to another positive quarter, and we look forward to seeing how it all unfolds.”

Sustainable Green Team, through its subsidiaries, including National Storm Recovery LLC (DBA Central Florida Arbor Care and Mulch Manufacturing Inc.), provides tree services, debris hauling, removal and bio-mass recycling, manufacturing, packaging and sales of next-generation mulch products. The company’s primary corporate objective is to provide a solution for the treatment and handling of tree debris that is historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation.

To learn more about Sustainable Green Team Ltd., view the company’s investor presentation at http://ibn.fm/N785O

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

• Pharmaceutical supplies and services innovator Trxade Group Inc. has announced a new B2B resource that bundles telemedicine services that may prove particularly useful for companies during the ongoing pandemic period
• Trxade Group’s new Bonum+ platform combines the power of telehealth consultation, AI-driven COVID-19 risk assessment and streamlined personal protective equipment purchasing to help manage employees’ care and performance
• The company is an emerging web-based presence in the wellness market that builds trust and independent pharmacy purchasing power through drug pricing transparency
• The company has achieved more than 50 percent penetration among the nation’s approximately 22,000 independent pharmacies.

Trxade Group (NASDAQ: MEDS) is expanding the B2B functionality of its supply chain trading platform through a first-of-its-kind bundled service that combines telehealth performance, a COVID-19 risk assessment tool and a personal protective equipment (“PPE”) purchasing tool to help businesses better deal with the medical needs of their internal corporate structures during an era of pandemic and beyond.

The company’s Bonum+ platform (http://ibn.fm/AAgH9) builds on the Bonum Health Hub wellness brand that has established a web-accessible medical consultation service in conjunction with an online prescription pharmaceutical presence (http://ibn.fm/D0N1Y) and the company’s app-accessible DelivMeds same-day / mail order pharmaceuticals delivery service (http://ibn.fm/wnW0S).

“This platform resolves a fundamental trust problem impacting employer’s safety and security policies, allowing companies to more effectively combat COVID-19 concerns in the workplace,” Bonum Health President Ashton Maaraba stated in the company’s most recent announcement. “Looking forward, we plan to continue to expand the breadth of services offered by Bonum Health, including adding a digital health hub with next-generation prescription concierge services.”

The Bonum+ platform centralizes communication and provides tools for COVID-19 contact tracing that helps companies assess employee risk profiles and respond as necessary with new PPE resources. The platform also offers health recommendations and connects employees with board certified physicians when needed, utilizing integrated artificial intelligence to streamline processes.

Trxade Group has distinguished itself as a web-based presence in the wellness market that emphasizes transparency in the pharmaceutical purchasing pipeline, empowering subscribers to assess drug prices and supply availability to make best product ordering decisions.

The company’s flagship platform has achieved more than 50 percent market penetration in attracting nearly 12,000 of the United States’ estimated 22,000 independent pharmacies so far, helping them to become more competitive with large pharmaceutical retail chains.

“Our platform lets these independents know that they’re receiving a fair price from competing suppliers on fair payment terms and often with next day delivery,” Founder, Chairman and CEO Suren Ajjarapu said in a recent earnings conference call (http://ibn.fm/HDLeo). “We believe this radical price transparency, economy of scale and competition amongst suppliers leads (to) up to 10% reduction in pharmacies’ total annual drug purchase costs, with a drug-level savings of up to 90% on certain pharmaceutical products.”

Trxade Group thereby saves pharmacists from labor-intensive cost comparisons between pharmaceutical distributors on a repetitive basis, profiting through a fee structure similar in nature to the ones employed by merchandising pioneers such as PayPal and Visa.

The company’s second quarter financial report notes that revenues increased 244 percent year-over-year for the quarter, and by 199 percent sequentially from the first quarter of the year.

“We believe that we are well positioned to execute upon the immense opportunity facing us today, supporting critical public health efforts nationwide,” Maaraba stated.

For more information, visit the company’s website at www.TrxadeGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS